首页 | 本学科首页   官方微博 | 高级检索  
     

冠心病患者血小板和淋巴细胞比值与冠脉斑块稳定性及预后的相关性
引用本文:朱志远,王海燕,吴波,王宏宝,李微,白旭东,任燕妮,何雪琴,周坛,戴军. 冠心病患者血小板和淋巴细胞比值与冠脉斑块稳定性及预后的相关性[J]. 现代检验医学杂志, 2019, 0(4): 112-115. DOI: 10.3969/j.issn.1671-7414.2019.04.027
作者姓名:朱志远  王海燕  吴波  王宏宝  李微  白旭东  任燕妮  何雪琴  周坛  戴军
作者单位:(同济大学附属杨浦医院安图分院心内科,上海 200093)
摘    要:目的 研究冠心病(coronary heart disease,CHD)患者血小板与淋巴细胞比值(platelet lymphocyte ratio,PLR)对冠脉斑块稳定性和预后的影响。方法 测定62例CHD患者(CHD组)及30例健康体检者(对照组)的血细胞检测和血糖、血压、血脂、肝肾功等生化指标。根据斑块性质分为易损斑块组(n=35)和稳定斑块组(n=27); 根据入院时PLR值分为低PLR组(n=30)和高PLR组(n=32)。比较各组临床指标,分析PLR对CHD患者斑块稳定性和预后的影响。结果 各组高血压病史(0,40.74%,48.57%),糖尿病病史(0,18.52%,42.86%),CRP(8.54±1.57,9.39±1.84,10.70±2.56)mg/L,Scr(50.84±10.87,61.27±13.16,75.18±15.54)μmol/L,BUN(5.37±0.50,6.91±1.17,8.48±2.05)mmol/L,FIB(2.76±0.39,3.14±0.54,3.36±0.66)g/L,PLT(181.43±43.48,229.26±50.87,238.47±47.93)×109/L,LYM(2.23±0.65,1.86±0.62,1.80±0.77)×109/L和PLR(95.75±24.72,112.43±24.48,131.83±26.81)比较,差异均有统计学意义(tχ2为3.4662.96,P<0.05)。多因素logistics回归分析显示,CRP(OR=2.29,95CI%:1.78~2.74),FIB(OR=2.03,95CI%:1.18~2.86)和PLR(OR=3.25,95CI%:1.88~4.61)均是CHD患者冠脉斑块不稳定的独立危险因素(P=0.007,0.004,0.000)。CRP,FIB和PLR联合预测CHD患者冠脉斑块稳定性的敏感度、特异度分别为83.1%和81.9%,均显著高于三个指标单独评估的敏感度、特异度(P<0.05)。高PLR组不良心血管事件(MACE)的发生率47.0%,显著高于低PLR组(20.00%),差异有统计学意义(χ2=4.09,P=0.043)。结论 PLR是CHD患者冠脉斑块稳定性的独立危险因素,且与预后密切相关,有助于指导临床决策。

关 键 词:血小板与淋巴细胞比值  冠心病  冠脉斑块稳定性  预后

Correlation between Ratio of Platelet to Lymphocytewith the Stability of Coronary Artery Plaque and Prognosisin Patients with Coronary Heart Disease
ZHU Zhi-yuan,WANG Hai-yan,WU Bo,WANG Hong-bao,LIWei,BAI Xu-dong,REN Yan-ni,HE Xue-qin,ZHOU Tan,DAI Jun. Correlation between Ratio of Platelet to Lymphocytewith the Stability of Coronary Artery Plaque and Prognosisin Patients with Coronary Heart Disease[J]. Journal of Modern Laboratory Medicine, 2019, 0(4): 112-115. DOI: 10.3969/j.issn.1671-7414.2019.04.027
Authors:ZHU Zhi-yuan  WANG Hai-yan  WU Bo  WANG Hong-bao  LIWei  BAI Xu-dong  REN Yan-ni  HE Xue-qin  ZHOU Tan  DAI Jun
Affiliation:(Department of Cardiology,Antu Branch,Yangpu Hospital of Tongji University,Shanghai 200093,China)
Abstract:Objective To explore the effects of platelet-lymphocyte ratio(PLR)on the stability of coronary artery plaque and prognosis in patients with coronary heart disease(CHD).Methods Blood routine,blood glucose,blood pressure,blood lipids,liver and kidney function were determined in 62 CHD patients(CHD group)and 30 healthy subjects(control group).According to the nature of plaque,patients were divided into vulnerable plaque group(n=35)and stable plaque group(n=27).According to thePLR value on admission,patients were divided into low PLR group(n=30)andhigh PLR group(n=32).Clinical indicators of each group were compared,andthe influence of PLR on plaque stability and prognosis of CHD patients was analyzed.Results There was significant difference on historyof diabetes(0,40.74%,48.57%)and hypertension(0,18.52%,42.86%),CRP(8.54±1.57,9.39±1.84,10.70±2.56)mg/L,Scr(50.84±10.87,61.27±13.16,75.18±15.54)μmol/L,BUN(5.37±0.50,6.91±1.17,8.48±2.05)mmol/L,FIB(2.76±0.39,3.14±0.54,3.36±0.66)g/L,PLT(181.43±43.48,229.26±50.87,238.47±47.93)×109/L,LYM(2.23±0.65,1.86±0.62,1.80±0.77)×109/L and PLR(95.75±24.72,112.43±24.48,131.83±26.81),among each group(t/χ2=3.46~62.96,all P<0.05).Multiple logisticsregression analysis showed that CRP(OR=2.29,95CI%:1.78~2.74),FIB(OR=2.03,95CI%:1.18~2.86)and PLR(OR=3.25,95CI%:1.88~4.61)were independentrisk factors for coronary plaque instability in CHD patients(P=0.007,0.004,0.000).The sensitivity and specificity of combined detection of CRP,FIB and PLR to predict the stability of coronary artery plaque were 83.1% and 81.9%,respectively,which were significantly higher than separate detection(P<0.05).Theincidence of MACE in high PLR group was 47.0%,significantly higher than 20.00% in low PLR group(χ2=4.09,P=0.043),respectively.Conclusion PLR is independent risk factors for stability of coronary artery plaque in CHD patients,and closely related to the prognosis,it helps to guide the clinical decision.
Keywords:
本文献已被 CNKI 等数据库收录!
点击此处可从《现代检验医学杂志》浏览原始摘要信息
点击此处可从《现代检验医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号